Crinetics Pharmaceuticals (CRNX) Capital Expenditures Growth (1y) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 143.40% |
| 10 | Crinetics Pharmaceuticals | 8.73 Bn | 7.44 Bn | 10.53 Mn | 75.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.76% |
| Dec 31, 2025 | -91.22% |
| Sep 30, 2025 | -1,432.87% |
| Jun 30, 2025 | 524.49% |
| Mar 31, 2025 | -80.18% |
| Dec 31, 2024 | 749.89% |
| Sep 30, 2024 | -173.71% |
| Jun 30, 2024 | -4,378.26% |
| Mar 31, 2024 | 8,225.00% |
| Dec 31, 2023 | 132.20% |
| Sep 30, 2023 | -70.15% |
| Jun 30, 2023 | 560.00% |
| Mar 31, 2023 | -81.61% |
| Dec 31, 2022 | -7,777.78% |
| Sep 30, 2022 | 211.00% |
| Jun 30, 2022 | 76.19% |
| Mar 31, 2022 | 314.29% |
| Dec 31, 2021 | 5.88% |
| Sep 30, 2021 | 330.93% |
| Jun 30, 2021 | -275.00% |